People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Evolve Biosystems, Inc. | — | Biotechnology | Series A | $9.0M | $325.4M | 2015 |
David J. Kyle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. Kyle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel Bruce Janney | 1 | 1 |
| John Bruce Campbell | 1 | 1 |
| J. Bruce German | 1 | 1 |
| James J. Campbell | 1 | 1 |
| David J. Mills | 1 | 1 |
| Catherine Bruce Mackey | 1 | 1 |
| Anne Bruce Lo | 1 | 1 |
| Simon Bruce Barnes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.